Winning Health convertible bond faces potential conversion price revision

Winning Health Technology Group's convertible bonds, known as "Winning Convertible Bond," are facing a potential downward revision of their conversion price. As of November 3, 2025, the company's stock has traded below 85% of its current conversion price of 17.31 per share (i.e., below 14.71 per share) for 10 trading days between October 21, 2025, and November 3, 2025. This trend indicates that the conditions for a downward adjustment are likely to be met.

According to the bond prospectus, if the company's stock closing price falls below 85% of the current conversion price for at least 15 out of 30 consecutive trading days, the board of directors can propose a downward revision. The company will convene a board meeting when the conditions are met to decide whether to adjust the conversion price and will promptly disclose the information.

The "Winning Convertible Bond" was issued on March 16, 2021, with a total value of 970.2650m. The bond's conversion period runs from September 22, 2021, to March 15, 2027. Investors are advised to pay attention to investment risks.